Advertisement
Global  

“News neutrality by unbiased coverage”
One News Page
> >

Lung cancer patients live longer with immune therapy

CBC.ca Monday, 16 April 2018
For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.
0
shares
ShareTweetSavePostSend
 
Source: Wochit News - < > Embed
News video: Lung Cancer Patients Fair Better with Immune Therapy

▶ Lung Cancer Patients Fair Better with Immune Therapy 00:45

According to a new report, lung cancer patients live longer while on immune therapy. Using a combination of immunotherapy drugs, doctors found that pre-treating lung cancer patients before surgery can help eat away at tumors, while helping patients recover from the affects of chemotherapy. A lung...

You Might Like


Recent related news

TP Therapeutics Announces Updated Interim Phase 1/2 Clinical Trial Data of Repotrectinib (TPX-0005) in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer Patients at 19th World Conference on Lung Cancer

TP Therapeutics Announces Updated Interim Phase 1/2 Clinical Trial Data of Repotrectinib (TPX-0005) in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer Patients at 19th World Conference on Lung Cancer
SAN DIEGO--(BUSINESS WIRE)--TP Therapeutics Announces Updated Interim Phase 1/2 Clinical Trial Data of Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung...
Business Wire - Press Releases

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA)...
Business Wire - Press Releases

Roche's Tecentriq adds two months to lung cancer patients' lives: study

A drug cocktail with Roche's Tecentriq added two months to small-cell lung cancer patients' lives, potentially aiding the Swiss company's bid to win approval in...
Reuters - HealthAlso reported by •GlobeNewswireScience Daily

Thermal Ablation Effectively Treats Early-stage Lung Cancer

Thermal ablation is a safe, effective treatment for early-stage lung cancer, according to a study published in the journal Radiology. The results show that...
PRWeb - Press Releases


Tweets about this

CandIbyYolanda

TXCandIGirl RT @CedEntertainer: On Sept. 7, two powerful events to save the lives of cancer patients everywhere. Tune in to the @SU2C digital live show… 1 day ago

bschrul

Bill Schrul RT @LCAorg: "On 6/1/2017, I was diagnosed with stg IV #lungcancer, at the age of 29. My wife, Emily + I are confident that by raising aware… 1 day ago


Other recent news in Health

Gujarat: Most PEOPLE with diabetes uninformed on retinal healthStudy: ROUNDUP WEED KILLER COULD Be Linked To Widespread Bee Deaths

Recent related videos

La Crescent LizFest raises awareness, funds for lung cancer [Video]La Crescent LizFest raises awareness, funds for lung cancer

Another festival in our area is celebrating life while raising money for lung cancer patients.

WKBT -  

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+  •  FOLLOW us on Pinterest